Supplemental material
Modern Rheumatology
Volume 27, 2017 - Issue 2
Open access
3,600
Views
26
CrossRef citations to date
0
Altmetric
Original Article
Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study
Naoki IshiguroDepartment of Orthopedic Surgery, Nagoya University Graduate School & Faculty of Medicine, Nagoya, Japan, Correspondence[email protected]
, Tatsuya AtsumiHokkaido University Graduate School of Medicine, Sapporo, Japan,
, Masayoshi HarigaiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan,
, Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan,
, Norihiro NishimotoOsaka Rheumatology Clinic, Tokyo Medical University, Osaka, Japan,
, Takayuki SumidaDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan,
, Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University, Minato, Japan,
, Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan,
, Ayako NakasonePharmacovigilance Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan,
, Nobuhiro TakagiMedical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan, and
& Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
show all
Pages 217-226
|
Received 10 Mar 2016, Accepted 14 Jun 2016, Published online: 14 Jul 2016
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.